The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Bcl-2 and the regulation of programmed cell death
Reed, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.1 · Cited by 2,305
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,593
Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.367 · Cited by 1,567
Action of 2',2'-difluorodeoxycytidine on DNA synthesis.
Huang, P., Chubb, S., Hertel, L. W., Grindey, G. B., & Plunkett, W. K. (1991) · PubMed · Cited by 876
5′-Nucleotidase: molecular structure and functional aspects
Zimmermann, H. (1992) · Biochemical Journal · doi:10.1042/bj2850345 · Cited by 870
Poly(ADP-ribose) polymerase: a molecular nick-sensor
de Murcia, G., & de Murcia, J. M. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90280-1 · Cited by 797
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
Abbruzzese, J. L., Grunewald, R., Weeks, E. A., Gravel, D., Adams, T., Nowak, B., Mineishi, S., Tarassoff, P., Satterlee, W., & Raber, M. N. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.491 · Cited by 759
Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
Plunkett, W. K., Huang, P., Xu, Y.-Z., Heinemann, V., Grunewald, R., & Gandhi, V. V. (1995) · PubMed · Cited by 753
Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita, T., Harigai, M., Hanada, M., & Reed, J. C. (1994) · PubMed · Cited by 743
Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., et al. (1995) · Blood · doi:10.1182/blood.v85.6.1580.bloodjournal8561580 · Cited by 732
Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C. M., et al. (1998) · Blood · doi:10.1182/blood.v91.9.3379 · Cited by 651
Mackey, J. R., Mani, R. S., Selner, M., Mowles, D., YOUNG, J., Belt, J. A., Crawford, C. R., & Cass, C. E. (1998) · PubMed · Cited by 599
Self-citationWattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P., & Fenaux, P. (1994) · Blood · doi:10.1182/blood.v84.9.3148.3148 · Cited by 591
Mammalian deoxyribonucleoside kinases
Arnér, E. S. J., & Eriksson, S. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00015-9 · Cited by 577
Heinemann, V., Hertel, L. W., Grindey, G. B., & Plunkett, W. K. (1988) · PubMed · Cited by 504
Griffiths, M., Beaumont, N., Yao, S. Y. M., Sundaram, M., Boumah, C. E., Davies, A., Kwong, F. Y. P., Coe, I., Cass, C. E., Young, J. D., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-89 · Cited by 422
Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
Seto, S., Carrera, C. J., Kubota, M., Wasson, D. B., & Carson, D. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111710 · Cited by 382
el Rouby, S., Thomas, A., Costin, D., Rosenberg, C., Potmesil, M., Silber, R., & Newcomb, E. (1993) · Blood · doi:10.1182/blood.v82.11.3452.3452 · Cited by 374
ADP-ribosylation of proteins. Enzymology and biological significance.
Althaus, F. R., & Richter, C. (1987) · PubMed · Cited by 371
Correlation of cytotoxicity with incorporation of ara-C into DNA.
Kufe, D. W., Major, P. P., Egan, E. M., & Beardsley, G. P. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70512-2 · Cited by 360
Nucleoside transporters: molecular biology and implications for therapeutic development
Baldwin, S. A., Mackey, J. R., Cass, C. E., & Young, J. D. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01459-8 · Cited by 349
Self-citationEcto‐enzyme and signaling functions of lymphocyte CD 7 3
Resta, R., Yamashita, Y., & Thompson, L. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01574.x · Cited by 332
Gandhi, V, Estey, E., Keating, M. J., & Plunkett, W. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.116 · Cited by 331
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
Crinò, L., Scagliotti, G., Marangolo, M., Figoli, F., Clerici, M., De Marinis, F., Salvati, F., Cruciani, G., Dogliotti, L., Pucci, F., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.297 · Cited by 303
Genini, D., Adachi, S., Chao, Q., Rose, D. W., Carrera, C. J., Cottam, H. B., Carson, D. A., & Leoni, L. M. (2000) · Blood · doi:10.1182/blood.v96.10.3537 · Cited by 290
Cytarabine and neurologic toxicity.
Baker, W. J., Royer, G. L., & Weiss, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.679 · Cited by 285
Preclinical characteristics of gemcitabine
Plunkett, W., Huang, P., & Gandhi, V. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199512006-00002 · Cited by 283
GRIFFITHS, M., YAO, Y. M. S., ABIDI, F., PHILLIPS, E. V. S., CASS, E. C., YOUNG, D. J., & BALDWIN, A. S. (1997) · Biochemical Journal · doi:10.1042/bj3280739 · Cited by 277
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes
Carson, D., Wasson, D., Taetle, R., & Yu, A. L.-T. (1983) · Blood · doi:10.1182/blood.v62.4.737.737 · Cited by 276
Thomas, A., Rouby, S. E., Reed, J. C., Krajewski, S., Silber, R.-E., Potmĕsil, M., & Newcomb, E. (1996) · PubMed · Cited by 265
Baker, C. H., Banzon, J., Bollinger, J. M., Stubbe, J., Samano, V., Robins, M. J., Lippert, B., Jarvi, E., & Resvick, R. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00110a019 · Cited by 253
2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines
Ruiz van Haperen, V. W. T., Veerman, G., Vermorken, J. B., & Peters, G. J. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90566-f · Cited by 253
Goan, Y.-G., Zhou, B., Hu, E., Mi, S., & Yen, Y. (1999) · PubMed · Cited by 227
Crawford, C. R., Patel, D. H., Naeve, C. W., & Belt, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5288 · Cited by 222
Meuth, M. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90090-6 · Cited by 217
Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute Leukemia
Wiley, J. S., Jones, S. P., Sawyer, W. H., & Paterson, A. R. P. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110472 · Cited by 212
Parker, W. B., Shaddix, S. C., Chang, C., White, E. L., Rose, L. M., Brockman, R. W., Shortnacy, A. T., Montgomery, J. A. J., Secrist, J. A. I., & Bennett, L. L. (1991) · PubMed · Cited by 207
Huang, P., Chubb, S., & Plunkett, W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46267-3 · Cited by 206
Löwenberg, B., Suciu, S., Archimbaud, E., Ossenkoppele, G. J., Verhoef, G. E. G., Vellenga, E., Wijermans, P., Berneman, Z. N., Dekker, A. W., Stryckmans, P. A., et al. (1997) · PubMed · doi:10.1182/blood.v90.8.2952 · Cited by 205
Major, P. P., Egan, E. M., Beardsley, G. P., Minden, M. D.-V., & Kufe, D. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3235 · Cited by 197
Gunji, H., Kharbanda, S. M., & Kufe, D. W. (1991) · PubMed · Cited by 192
Bettelheim, P., Valent, P., Andreeff, M., Tafuri, A., Haimi, J., Gorischek, C., Muhm, M., Sillaber, C., Haas, O., & Vieder, L. (1991) · Blood · doi:10.1182/blood.v77.4.700.700 · Cited by 185
Kawasaki, H., Carrera, C., Piro, L., Saven, A., Kipps, T., & Carson, D. (1993) · Blood · doi:10.1182/blood.v81.3.597.597 · Cited by 184
S-Phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs
Bjoerklund, S., Skog, S., Tribukait, B., & Thelander, L. (1990) · Biochemistry · doi:10.1021/bi00475a007 · Cited by 179
New antimetabolites in cancer chemotherapy and their clinical impact
Kaye, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.747 · Cited by 177
Wang, L., Munch-Petersen, B., Herrström Sjöberg, A., Hellman, U., Bergman, T., Jörnvall, H., & Eriksson, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01711-6 · Cited by 167
Misumi, Y., Ogata, S., Ohkubo, K., Hirose, S., & Ikehara, Y. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19158.x · Cited by 167
Genini, D., Budihardjo, I., Plunkett, W., Wang, X., Carrera, C. J., Cottam, H. B., Carson, D. A., & Leoni, L. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.29 · Cited by 164
Nucleoside transport in normal and neoplastic cells
Belt, J. A., Marina, N. M., Phelps, D. A., & Crawford, C. R. (1993) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(93)90021-5 · Cited by 163
Gandhi, V, Estey, E., Keating, M., Chucrallah, A., & Plunkett, W. (1996) · Blood · doi:10.1182/blood.v87.1.256.256 · Cited by 162
Induction of apoptosis by gemcitabine.
Huang, P., & Plunkett, W. (1995) · PubMed · Cited by 157
McConkey, D. J., Chandra, J., Wright, S. J., Plunkett, W. K., McDonnell, T. J., Reed, J. C., & Keating, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2624 · Cited by 154
Ohno, R., Naoe, T., Kanamaru, A., Yoshida, M., Hiraoka, A., Kobayashi, T., Ueda, T., Minami, S., MORISHIMA, Y., & Saito, Y. (1994) · Blood · doi:10.1182/blood.v83.8.2086.2086 · Cited by 153
Dumontet, C., Fabianowska‐Majewska, K., Mantincic, D., Callet‐Bauchu, E., Tigaud, I., Gandhi, V. V., Lepoivre, M., Peters, G. J., Rolland, M. O., Wyczechowska, D. D., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01509.x · Cited by 151
Self-citationFludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies.
Plunkett, W., Gandhi, V., Huang, P., et al. (1993) · PubMed · Cited by 150
Nucleoside transport and its significance for anticancer drug resistance
MACKEY, J., Baldwin, S. A., YOUNG, J., & Cass, C. E. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80047-2 · Cited by 149
Self-citationParker, W. B., Bapat, A. R., Shen, J. X., Townsend, A. J., & Cheng, Y. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09779-2 · Cited by 145
Carson, D. A., Kaye, J., & Wasson, D. B. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.1.348 · Cited by 142
Grove, K. L., Guo, X., Liu, S., Gao, Z., Chu, C. K., & Cheng, Y.-T. (1995) · PubMed · Cited by 142
Metabolism and action of purine nucleoside analogs
Plunkett, W. K., & Saunders, P. P. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90057-s · Cited by 141
Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
Neff, T., & Blau, C. A. (1996) · PubMed · Cited by 139
Leoni, L. M., Chao, Q., Cottam, H. B., Genini, D., Rosenbach, M., Carrera, C. J., Budihardjo, I. I., Wang, X., & Carson, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9567 · Cited by 129
Cloning of the cDNA and Chromosome Localization of the Gene for Human Thymidine Kinase 2
Johansson, M., & Karlsson, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8454 · Cited by 127
Bhalla, K. N., Nayak, R., & Grant, S. (1984) · PubMed · Cited by 125
Metabolism and action of fludarabine phosphate.
Plunkett, W. K., Huang, P., & Gandhi, V. V. (1990) · PubMed · Cited by 117
Varterasian, M. L., Mohammad, R. M., Eilender, D., Hulburd, K., Rodriguez, D. H., Pemberton, P. A., Pluda, J. M., Dan, M., Pettit, G. R., Chen, B. D. M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.56 · Cited by 114
Iwasaki, H., Huang, P., Keating, M. J., & Plunkett, W. K. (1997) · Blood · doi:10.1182/blood.v90.1.270 · Cited by 111
Ohno, Y., Spriggs, D. R., Matsukage, A., Ohno, T., & Kufe, D. W. (1988) · PubMed · Cited by 105
Mutagenesis and deoxyribonucleotide pool imbalance
Kunz, B. A. (1988) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(88)90076-0 · Cited by 103
Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Wiley, J. S., Taupin, J., Jamieson, G. P., Snook, M. B., Sawyer, W. H., & Finch, L. R. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111741 · Cited by 101
Gandhi, V. V., Kemena, A., Keating, M. J., & Plunkett, W. K. (1992) · PubMed · Cited by 99
Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes.
Lømo, J., Smeland, E. B., Krajewski, S., Reed, J. C., & Blomhoff, H. K. (1996) · PubMed · Cited by 96
Gati, W. P., Paterson, A. R. P., Larratt, L. M., Turner, A. R., & Belch, A. R. (1997) · Blood · doi:10.1182/blood.v90.1.346 · Cited by 95
p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis
Lens, D., Dyer, M. J. S., Garcia‐Marco, J. M., Schouwer, P. J. J. C. D., Hamoudi, R., Jones, D., Farahat, N. M. G., Matutes, E., & Catovsky, D. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4723278.x · Cited by 95
Selective toxicity of deoxyguanosine and arabinosyl guanine for T- leukemic cells
Cohen, A., Lee, J., & Gelfand, E. W. (1983) · Blood · doi:10.1182/blood.v61.4.660.660 · Cited by 92
Huang, P., Sandoval, A., Neste, E. V. D., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401845 · Cited by 91
Nucleoside transport in L1210 murine leukemia cells. Evidence for three transporters.
Crawford, C. R., Ng, C. Y., Noel, L. D., & Belt, J. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38732-0 · Cited by 86
Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells
Nyce, J. W., Liu, L., & Jones, P. A. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.10.4353 · Cited by 84
Ross, S. R., McTavish, D., & Faulds, D. M. (1993) · Drugs · doi:10.2165/00003495-199345050-00009 · Cited by 82
1-β-arabinofuranosylcytosine in therapy of leukemia: Preclinical and clinical overview
Rustum, Y. M., & Raymakers, R. A. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90022-r · Cited by 80
Gottardi, D., Alfarano, A., Leo, A. M. D., Stacchini, A., Aragno, M., Rigo, A., Veneri, D., Zanotti, R., Pizzolo, G., & Caligaris‐Cappio, F. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1856.x · Cited by 79
Grove, K. L., & Cheng, Y. (1996) · PubMed · Cited by 78
P53, MDM-2, BAX and BCL-2 and Drug Resistance in Chronic Lymphocytic Leukemia
Johnston, J. B., Daeninck, P. J., Verburg, L., Lee, K., Williams, G. J., Israels, L. G., Mowat, M. R. A., & Begleiter, A. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709050881 · Cited by 78
Boleti, H., Coe, I. R., Baldwin, S. A., Young, J. D., & Cass, C. E. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00136-6 · Cited by 77
Flaßhove, M., Strumberg, D., Ayscue, L. H., Mitchell, B. S., Tirier, C., Heit, W. F. W., Seeber, S., & Schütte, J. (1994) · PubMed · Cited by 77
Momparler, R. L., Côté, S., & Eliopoulos, N. (1997) · Leukemia · doi:10.1038/sj.leu.2400550 · Cited by 70
Enríquez, J. A., Fernández‐Silva, P., Martos, A. P., López-Pérez, M. J., & Montoya, J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0601p.x · Cited by 68
Rampazzo, C., Johansson, M., Gallinaro, L., Ferraro, P., Hellman, U., Karlsson, A., Reichard, P. A., & Bianchi, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5409 · Cited by 63
Yang, L., Li, L., Keating, M. J., & Plunkett, W. K. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08597-9 · Cited by 60
New antimetabolites in the treatment of human malignancies.
Cheson, B. D. (1992) · PubMed · Cited by 58
Programmed cell death and adenine deoxynucleotide metabolism in human lymphocytes
Carson, D. A., Carrera, C. J., Wasson, D. B., et al. (1988) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(88)90028-3 · Cited by 58
Graham, K., Leithoff, J., Coe, I. R., Mowles, D., Mackey, J. R., Young, J. D., & Cass, C. E. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033018 · Cited by 57
Self-citationSasvári‐Székely, M., Spasokoukotskaja, T., Szöke, M., Csapó, Z., Turi, Á., Szántó, I., Eriksson, S., & Staub, M. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00108-7 · Cited by 53
Hentosh, P., Koob, R., & Blakley, R. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39698-x · Cited by 49
Zaja, F. F., Diloreto, C., Amoroso, V., Salmaso, F., Russo, D., Silvestri, F. F., Fanin, R., Damiani, D., Infanti, L., Mariuzzi, L., et al. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809058365 · Cited by 46
Lauria, F., Rondelli, D., Zinzani, P. L., Bocchia, M., Marotta, G., Salvucci, M., Raspadori, D., Ventura, M. A., Birtolo, S., Forconi, F., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400619 · Cited by 46
Reuter, C. W., der Landwehr, U. A., Schleyer, E., Zühlsdorf, M., Ameling, C., Rolf, C., Wormann, B. J., Büchner, T., & Hiddemann, W. (1994) · PubMed · Cited by 46
Schirmer, M., Stegmann, A. P. A., Geisen, F. H., et al. (1998) · PubMed · Cited by 45
Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage.
Feng, L., Achanta, G., Pelicano, H., Zhang, W., Plunkett, W. K., & Huang, P. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.5.6.597 · Cited by 43
Mohammad, R. M., Beck, F. W. J., Katato, K., Hamdy, N., Wall, N. R., & Al-Katib, A. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.10.1253 · Cited by 32
Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-AZA-2′-deoxycytidine
Momparler, R. L., & Laliberté, J. (1990) · Leukemia Research · doi:10.1016/0145-2126(90)90067-j · Cited by 27
Hentosh, P., & TIBUDAN, M. L. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.613 · Cited by 19
Mohammad, R. M., Limvarapuss, C., Hamdy, N., Dutcher, B. S., Beck, F. W., Wall, N. R., & Al-Katib, A. M. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.5.945 · Cited by 15
Cited by
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Mechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660
Nucleoside analogues and nucleobases in cancer treatment
Galmarini, C. M., Mackey, J. R., & Dumontet, C. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00788-x · Cited by 606
Self-citationNervi, B., Ramirez, P., Rettig, M. P., Uy, G. L., Holt, M. S., Ritchey, J. K., Prior, J. L., Piwnica-Worms, D., Bridger, G., Ley, T. J., et al. (2009) · Blood · doi:10.1182/blood-2008-06-162123 · Cited by 491
Spratlin, J., Sangha, R., Glubrecht, D., Dabbagh, L., Young, J. D., Dumontet, C., Cass, C., Lai, R., & Mackey, J. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0224 · Cited by 430
Self-citation
Metadata
- Authors
- Galmarini, C., Mackey, Jr., & Dumontet, C.
- Venue
- Leukemia
- Published
- 2001-06-01
- Volume
- 15
- Issue
- 6
- Pages
- 875-890
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2030873172
- Cited by
- 511
- References
- 106
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.